Neurobiology of Cancer: the Role of β-Adrenergic Receptor Signaling in Various Tumor Environments.
cancer
epinephrine
macroenvironment
microenvironment
norepinephrine
psychosocial factors
spirituality
stress
sympathoadrenal system
β-blockers
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
26 Oct 2020
26 Oct 2020
Historique:
received:
02
10
2020
revised:
21
10
2020
accepted:
26
10
2020
entrez:
29
10
2020
pubmed:
30
10
2020
medline:
4
3
2021
Statut:
epublish
Résumé
The development and progression of cancer depends on both tumor micro- and macroenvironments. In addition, psychosocial and spiritual "environments" might also affect cancer. It has been found that the nervous system, via neural and humoral pathways, significantly modulates processes related to cancer at the level of the tumor micro- and macroenvironments. The nervous system also mediates the effects of psychosocial and noetic factors on cancer. Importantly, data accumulated in the last two decades have clearly shown that effects of the nervous system on cancer initiation, progression, and the development of metastases are mediated by the sympathoadrenal system mainly via β-adrenergic receptor signaling. Here, we provide a new complex view of the role of β-adrenergic receptor signaling within the tumor micro- and macroenvironments as well as in mediating the effects of the psychosocial and spiritual environments. In addition, we describe potential preventive and therapeutic implications.
Identifiants
pubmed: 33114769
pii: ijms21217958
doi: 10.3390/ijms21217958
pmc: PMC7662752
pii:
doi:
Substances chimiques
Receptors, Adrenergic, beta
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Slovak Research and Development Agency
ID : APVV-17-0090
Organisme : VEGA
ID : 01/0136/18
Références
Science. 2013 Jul 12;341(6142):1236361
pubmed: 23846904
Palliat Support Care. 2015 Jun;13(3):673-81
pubmed: 24825576
Dev Biol. 2001 Jul 1;235(1):1-11
pubmed: 11412023
Cancer Immunol Res. 2018 Jan;6(1):98-109
pubmed: 29146881
Am J Transl Res. 2016 Nov 15;8(11):5059-5070
pubmed: 27904707
Nat Rev Cancer. 2020 Mar;20(3):143-157
pubmed: 31974491
Cancer Med. 2019 Jan;8(1):363-373
pubmed: 30600642
Radiat Res. 2014 Feb;181(2):111-30
pubmed: 24397478
Nature. 2019 May;569(7758):672-678
pubmed: 31092925
Brain Behav Immun. 2007 Aug;21(6):736-45
pubmed: 17467231
Asian J Androl. 2019 May-Jun;21(3):253-259
pubmed: 29848834
Brain Behav Immun. 2016 Oct;57:106-115
pubmed: 27321906
Arch Oral Biol. 2020 May;113:104712
pubmed: 32234582
Int J Oncol. 2015 Aug;47(2):527-34
pubmed: 26058426
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Circulation. 1994 Jul;90(1):248-53
pubmed: 8026005
Semin Cancer Biol. 2008 Jun;18(3):150-63
pubmed: 18201897
Oncol Rep. 2010 Dec;24(6):1669-76
pubmed: 21042766
Mol Cancer. 2011 Nov 26;10:146
pubmed: 22118662
Nat Commun. 2016 Mar 01;7:10634
pubmed: 26925549
Clin Cancer Res. 2012 Sep 15;18(18):4895-902
pubmed: 22753587
Nat Rev Cancer. 2017 Aug;17(8):457-474
pubmed: 28706266
J Neuroimmunol. 2018 Feb 15;315:15-23
pubmed: 29306400
Sci Rep. 2019 Jun 12;9(1):8565
pubmed: 31189941
Cancer. 2020 Sep 1;126(17):3991-4001
pubmed: 32533792
Front Immunol. 2018 Feb 06;9:164
pubmed: 29479349
Cell Death Dis. 2019 Oct 17;10(11):788
pubmed: 31624248
Nat Rev Clin Oncol. 2018 Apr;15(4):205-218
pubmed: 29283170
Adv Exp Med Biol. 2020;1219:93-107
pubmed: 32130695
Cancers (Basel). 2019 Jan 03;11(1):
pubmed: 30609850
Stress. 2016 Sep;19(5):528-34
pubmed: 27416924
Nat Med. 2018 Dec;24(12):1795-1803
pubmed: 30523327
J Relig Health. 2019 Apr;58(2):444-451
pubmed: 30225762
Diabetologia. 2000 May;43(5):533-49
pubmed: 10855527
Physiol Res. 2017 Sep 22;66(Suppl 2):S173-S185
pubmed: 28937233
Nat Commun. 2020 Jul 17;11(1):3606
pubmed: 32681016
Microbiology (Reading). 2007 Dec;153(Pt 12):3923-3938
pubmed: 18048907
Oncogene. 2017 Mar;36(11):1525-1536
pubmed: 27641328
Nat Rev Cancer. 2014 Mar;14(3):159-72
pubmed: 24561443
Oncogene. 2016 May 5;35(18):2390-7
pubmed: 26257064
Int J Mol Sci. 2020 Mar 24;21(6):
pubmed: 32213975
Cancer Res. 2019 Jul 15;79(14):3529-3535
pubmed: 31088834
Nat Rev Urol. 2020 Feb;17(2):119-130
pubmed: 31937919
Stress. 2016 Jul;19(4):419-28
pubmed: 27398826
N Engl J Med. 1980 Aug 21;303(8):436-44
pubmed: 6248784
Amino Acids. 2013 Jul;45(1):55-71
pubmed: 22160285
Brain Behav Immun. 2011 Feb;25(2):250-5
pubmed: 20955777
MAbs. 2020 Jan-Dec;12(1):1703531
pubmed: 31847708
Biology (Basel). 2020 Feb 22;9(2):
pubmed: 32098331
Pharmacol Rev. 2000 Dec;52(4):595-638
pubmed: 11121511
Eur J Oral Sci. 2009 Aug;117(4):351-61
pubmed: 19627344
J Neuroimmunol. 2020 Jul 3;346:577311
pubmed: 32652365
PLoS One. 2013 Apr 09;8(4):e61435
pubmed: 23585898
Cancer Immunol Immunother. 2019 Jan;68(1):11-22
pubmed: 30229289
Brain Behav Immun. 2016 Mar;53:223-233
pubmed: 26718447
Trends Cancer. 2018 Dec;4(12):802-809
pubmed: 30470302
Circ Res. 1998 Jul 27;83(2):187-95
pubmed: 9686758
Biopsychosoc Med. 2017 Nov 21;11:29
pubmed: 29201137
Compr Physiol. 2015 Jan;5(1):1-15
pubmed: 25589262
Curr Opin Immunol. 2018 Aug;53:64-73
pubmed: 29698919
JAMA Oncol. 2019 Jan 1;5(1):106-107
pubmed: 30489606
Clin Cancer Res. 2012 Mar 1;18(5):1201-6
pubmed: 22186256
Nat Med. 2006 Aug;12(8):939-44
pubmed: 16862152
Pathobiology. 2020;87(2):58-60
pubmed: 31484178
Biochimie. 2018 Jun;149:79-91
pubmed: 29654866
J Neuroimmunol. 2020 Jul 3;346:577312
pubmed: 32652364
Sao Paulo Med J. 2020 Jun;138(3):176-183
pubmed: 32267295
J Pathol. 2018 Jan;244(1):49-60
pubmed: 28940209
Gut. 1999 Feb;44(2):156-62
pubmed: 9895372
Neuroimmunomodulation. 2000;8(3):154-64
pubmed: 11124582
Physiol Rev. 2009 Apr;89(2):535-606
pubmed: 19342614
J Cell Physiol. 2016 Feb;231(2):459-72
pubmed: 26189563
Brain Behav Immun. 2019 Aug;80:825-838
pubmed: 31125710
Cancer Discov. 2019 Jun;9(6):702-710
pubmed: 30944117
J Obes. 2013;2013:291546
pubmed: 24073332
Stress. 2020 Jan;23(1):87-96
pubmed: 31311393
Appl Psychophysiol Biofeedback. 2020 Jun;45(2):99-108
pubmed: 32358782
J Drug Assess. 2020 Jul 23;9(1):106-116
pubmed: 32939316
Naunyn Schmiedebergs Arch Pharmacol. 2014 Jun;387(6):533-43
pubmed: 24599317
Curr Med Chem. 2009;16(15):1850-62
pubmed: 19442150
Annu Rev Physiol. 2005;67:259-84
pubmed: 15709959
Oncotarget. 2015 Mar 10;6(7):4615-32
pubmed: 25474135
Nature. 2020 Feb;578(7795):449-454
pubmed: 32051587
Biomed J. 2019 Jun;42(3):155-165
pubmed: 31466709
Curr Cancer Drug Targets. 2017;17(8):756-766
pubmed: 28359245
Am J Nucl Med Mol Imaging. 2012;2(3):314-34
pubmed: 23133819
Genes Dev. 2016 Mar 1;30(5):489-501
pubmed: 26944676
Oncoscience. 2017 Aug 23;4(7-8):95-105
pubmed: 28966942
Oncogenesis. 2016 Feb 22;5:e200
pubmed: 26900952
Cancer Metastasis Rev. 2013 Dec;32(3-4):603-21
pubmed: 23674223
Cell Rep. 2019 Jun 11;27(11):3305-3314.e13
pubmed: 31189113
Int J Mol Sci. 2018 Apr 03;19(4):
pubmed: 29614021
J Cell Sci. 2016 Dec 15;129(24):4563-4575
pubmed: 27875276
Nature. 2013 Apr 11;496(7444):159-61
pubmed: 23579662
Arch Oral Biol. 2020 Oct;118:104865
pubmed: 32801034
Breast Cancer Res Treat. 2019 Oct;177(3):603-610
pubmed: 31290053
Issues Ment Health Nurs. 2017 Mar;38(3):243-252
pubmed: 27929687
Semin Oncol. 2014 Apr;41(2):281-95
pubmed: 24787299
Anticancer Res. 2019 Jan;39(1):395-403
pubmed: 30591486
Cancer Immunol Res. 2019 Nov;7(11):1849-1863
pubmed: 31527069
Cancer. 2002 May 15;94(10):2552-60
pubmed: 12173320
Crit Rev Immunol. 2019;39(2):93-103
pubmed: 31679250
Nature. 2011 Aug 21;477(7364):349-53
pubmed: 21857681
BMB Rep. 2015 May;48(5):295-300
pubmed: 25748171
Scand J Gastroenterol. 2020 May;55(5):597-605
pubmed: 32412855
Oncol Rep. 2015 May;33(5):2513-20
pubmed: 25812650
Int J Mol Sci. 2020 Apr 28;21(9):
pubmed: 32354115
Int J Mol Sci. 2019 Dec 12;20(24):
pubmed: 31842339
Curr Opin Support Palliat Care. 2018 Mar;12(1):46-51
pubmed: 29251694
Brain Behav Immun. 2019 Oct;81:111-121
pubmed: 31176001
Front Med (Lausanne). 2020 Feb 25;7:61
pubmed: 32158764
Cancer. 2019 Jan 1;125(1):45-56
pubmed: 30291805
Brain Behav Immun. 2011 Mar;25(3):574-83
pubmed: 21187140
J Clin Invest. 2007 May;117(5):1137-46
pubmed: 17476343
Nat Rev Clin Oncol. 2015 Apr;12(4):213-26
pubmed: 25601442
Clin Cancer Res. 2020 Apr 15;26(8):1803-1811
pubmed: 31754048
Electron Physician. 2016 Mar 25;8(3):2175-80
pubmed: 27123227
Mol Med Rep. 2018 Apr;17(4):5213-5221
pubmed: 29393410
Endocr Regul. 2016 Oct 1;50(4):207-214
pubmed: 27941180
Cancer Microenviron. 2018 Jun;11(1):1-11
pubmed: 29502307
Cancer Sci. 2014 Jul;105(7):847-56
pubmed: 24815301
Nat Rev Immunol. 2006 Oct;6(10):715-27
pubmed: 16977338
J Infect Dis. 2007 May 1;195(9):1248-9
pubmed: 17396992
Pharmacology. 2017;99(1-2):57-66
pubmed: 27694752
Oncol Rep. 2011 Dec;26(6):1471-7
pubmed: 21833475
Psychoneuroendocrinology. 2007 Jun;32(5):470-9
pubmed: 17459596
Semin Cancer Biol. 2020 Oct;65:197-206
pubmed: 31891779
Hypertens Res. 2012 Jan;35(1):4-16
pubmed: 22048570
Oncol Lett. 2017 Sep;14(3):3846-3852
pubmed: 28927156
PLoS One. 2018 Aug 20;13(8):e0202515
pubmed: 30125310
J Cancer Res Clin Oncol. 2017 Feb;143(2):275-291
pubmed: 27709364
Psychooncology. 2018 Nov;27(11):2525-2530
pubmed: 30307088
Clin Cancer Res. 2017 Aug 15;23(16):4651-4661
pubmed: 28490464
Curr Oncol Rep. 2019 Feb 4;21(2):14
pubmed: 30715603